[225Ac]Ac-A9-3408
/ Alpha-9 Oncology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 25, 2025
A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma
(clinicaltrials.gov)
- P1 | N=50 | Not yet recruiting | Sponsor: Alpha-9 Oncology USA Inc.
New P1 trial • Eye Cancer • Melanoma • Mucosal Melanoma • Oncology • Solid Tumor • Uveal Melanoma
1 to 1
Of
1
Go to page
1